Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Eisai
Company Monitoring Page for Eisai
job ratings for Eisai
02/17/25
industry:
pharmaceutical
job title:
Oncology rep
company:
Eisai
job rating:
7
My manager gives educational feedback and is an inspiration
11/18/19
industry:
Big Pharma
company:
Eisai
job rating:
1
bad management
03/19/18
industry:
Big Pharma
company:
Eisai
job rating:
2
Micro managers
04/04/17
industry:
Neurology pharmaceutical Sales
job title:
Neurology salespecially specialist
company:
Eisai
job rating:
1
Poor pay, awful management, no respect for current reps kept through downsizing
latest headlines for company on cafepharma
Eisai lays out road map to blockbuster sales projections for Leqembi's 'milestone' 2027 year
Fierce Pharma
Tue, 03/25/25 - 09:43 pm
Tags:
Eisai
,
Leqembi
,
Alzheimer's disease
Eisai's abandoned Enhertu challenger set to live on at BlissBio
Fierce Biotech
Fri, 03/21/25 - 11:34 am
Tags:
Eisai
,
BB-1701
,
Bliss Bio
,
liquid biopsy
What’s driving pharma’s layoffs in 2025
Pharma Voice
Mon, 03/10/25 - 09:27 am
Tags:
layoffs
,
CRISPR Therapeutics
,
Galapagos
,
Atara Biotherapeutics
,
Bristol Myers Squibb
,
Eisai
,
Biogen
NICE agrees to look again at Alzheimer's drug Leqembi
Pharmaphorum
Thu, 03/6/25 - 10:59 am
Tags:
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
,
UK
,
NICE
New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer’s approach
Pharma Voice
Tue, 03/4/25 - 09:51 am
Tags:
Voyager Therapeutics
,
RNA
,
Alzheimer's disease
,
Eisai
,
Biogen
,
Eli Lilly
Australia stands firm on 'no' to Alzheimer's drug Leqembi
Pharmaphorum
Mon, 03/3/25 - 10:53 am
Tags:
Eisai
,
Biogen
,
Australia
,
Alzheimer's disease
,
Leqembi
Leqembi, after delay, gets back on track toward EU approval
BioPharma Dive
Sun, 03/2/25 - 09:35 pm
Tags:
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
,
Europe
Eisai to part ways with 121 employees amid new US restructuring effort
Fierce Pharma
Thu, 02/27/25 - 09:29 pm
Tags:
Eisai
,
restructuring
,
layoffs
Eisai execs flag Leqembi 'expansion phase' on the horizon as Alzheimer's med grows slowlym
Fierce Pharma
Tue, 02/11/25 - 09:41 pm
Tags:
Eisai
,
Leqembi
,
Alzheimer's disease
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Marketscreener
Fri, 01/31/25 - 11:16 am
Tags:
Eisai
,
Biogen
,
Alzheimer's disease
,
Leqembi
,
Europe
Biogen, Eisai Win Nod for Monthly Leqembi Maintenance Amid Stagnant Sales
BioPharma Dive
Mon, 01/27/25 - 11:24 am
Tags:
Biogen
,
Eisai
,
Leqembi
,
Alzheimer's disease
,
FDA
Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial
Fierce Pharma
Fri, 01/24/25 - 11:30 am
Tags:
Merck
,
Eisai
,
clinical trials
,
Keytruda
,
Lenvima
,
gastroesophageal adenocarcinoma
,
GI cancers
Alzheimer’s disease market expected to reach $19.3bn across the 8MM by 2033
Clinical Trials Arena
Fri, 01/10/25 - 11:18 am
Tags:
Alzheimer's disease
,
Eisai
,
Biogen
,
Eli Lilly
,
Alzheon
Eisai unit hands over $46M for Japanese rights to Newron’s schizophrenia add-on
Fierce Biotech
Sun, 12/15/24 - 10:48 pm
Tags:
Newron Pharma
,
Eisai
,
schizophrenia
,
evenamide
Eisai sunsets development, access program for withdrawn obesity med in Dravet syndrome
Fierce Pharma
Mon, 11/18/24 - 06:36 pm
Tags:
Eisai
,
obesity
,
lorcaserin
Eisai wins over European regulators on Alzheimer’s drug Leqembi
BioPharma Dive
Thu, 11/14/24 - 10:28 pm
Tags:
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
Eisai Cuts Fiscal 2024 Guidance for Biogen-Partnered Leqembi as Sales Disappoint Analysts
BioSpace
Sun, 11/10/24 - 09:27 pm
Tags:
Eisai
,
Biogen
,
Leqembi
,
earnings
,
Alzheimer's disease
Eisai dials back forecasts for Alzheimer's drug Leqembi
Pharmaphorum
Fri, 11/8/24 - 11:38 am
Tags:
Eisai
,
earnings
,
Leqembi
,
Alzheimer's disease
Eisai, Biogen eye 2025 approval for Leqembi autoinjector
Pharmaphorum
Fri, 11/1/24 - 10:57 am
Tags:
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
,
FDA
Leqembi's vial design could result in hundreds of millions in annual Medicare waste: study
Fierce Pharma
Mon, 10/14/24 - 11:13 pm
Tags:
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.